These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
611 related items for PubMed ID: 27354487
1. Polymicrobial biofilm formation by Candida albicans, Actinomyces naeslundii, and Streptococcus mutans is Candida albicans strain and medium dependent. Arzmi MH, Alnuaimi AD, Dashper S, Cirillo N, Reynolds EC, McCullough M. Med Mycol; 2016 Nov 01; 54(8):856-64. PubMed ID: 27354487 [Abstract] [Full Text] [Related]
2. Coaggregation of Candida albicans, Actinomyces naeslundii and Streptococcus mutans is Candida albicans strain dependent. Arzmi MH, Dashper S, Catmull D, Cirillo N, Reynolds EC, McCullough M. FEMS Yeast Res; 2015 Aug 01; 15(5):fov038. PubMed ID: 26054855 [Abstract] [Full Text] [Related]
3. Interactions between Streptococcus oralis, Actinomyces oris, and Candida albicans in the development of multispecies oral microbial biofilms on salivary pellicle. Cavalcanti IM, Del Bel Cury AA, Jenkinson HF, Nobbs AH. Mol Oral Microbiol; 2017 Feb 01; 32(1):60-73. PubMed ID: 26834007 [Abstract] [Full Text] [Related]
4. Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off points. Marcos-Zambrano LJ, Escribano P, Bouza E, Guinea J. Int J Med Microbiol; 2014 Nov 01; 304(8):1192-8. PubMed ID: 25224357 [Abstract] [Full Text] [Related]
11. Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model. Jiang Q, Stamatova I, Kainulainen V, Korpela R, Meurman JH. BMC Microbiol; 2016 Jul 12; 16(1):149. PubMed ID: 27405227 [Abstract] [Full Text] [Related]
12. In vitro study of biofilm formation and effectiveness of antimicrobial treatment on various dental material surfaces. Li L, Finnegan MB, Özkan S, Kim Y, Lillehoj PB, Ho CM, Lux R, Mito R, Loewy Z, Shi W. Mol Oral Microbiol; 2010 Dec 12; 25(6):384-90. PubMed ID: 21040512 [Abstract] [Full Text] [Related]
14. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans. Jafri H, Khan MSA, Ahmad I. Phytomedicine; 2019 Feb 15; 54():206-213. PubMed ID: 30668370 [Abstract] [Full Text] [Related]
15. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production. Marcos-Zambrano LJ, Escribano P, Bouza E, Guinea J. Med Mycol; 2016 Feb 15; 54(2):155-61. PubMed ID: 26543157 [Abstract] [Full Text] [Related]
19. The positive impact of Streptococcus mutans on the growth of Candida albicans within mixed-species biofilms and implications to dental health. Wang X, Yap SF, Ngeow YF. Malays J Pathol; 2024 Aug 15; 46(2):295-298. PubMed ID: 39207006 [Abstract] [Full Text] [Related]
20. Voriconazole inhibits cross-kingdom interactions between Candida albicans and Actinomyces viscosus through the ergosterol pathway. Deng L, Zou L, Wu J, Liu H, Luo T, Zhou X, Li W, Ren B. Int J Antimicrob Agents; 2019 Jun 15; 53(6):805-813. PubMed ID: 30818001 [Abstract] [Full Text] [Related] Page: [Next] [New Search]